We are evaluating the safety of MAQ-001, both alone and with other treatments, for patients with advanced cancers. This study aims to understand how well it works in this patient group.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced cancers, such as metastatic melanoma, lung cancer, renal cell carcinoma, Hodgkin’s lymphoma, MSI-high colon cancer, hepatocellular carcinoma, and gastric cancer, can be treated with immune checkpoint blockade therapies, which help the immune system recognize and attack cancer cells.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.